Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

E3 ubiquitin ligase Cbl-b in innate and adaptive immunity
Qingjun Liu, Hong Zhou, Wallace Y. Langdon, et al.
Cell Cycle (2014) Vol. 13, Iss. 12, pp. 1875-1884
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Targeting Cbl-b in cancer immunotherapy
Ryan C. Augustin, Riyue Bao, Jason J. Luke
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006007-e006007
Open Access | Times Cited: 50
Epidermal Growth Factor Signaling in Transformed Cells
Stephan Lindsey, Sigrid A. Langhans
International review of cell and molecular biology (2014), pp. 1-41
Open Access | Times Cited: 109
E3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3
Nicholas M. Chesarino, Temet M. McMichael, Jacob S. Yount
PLoS Pathogens (2015) Vol. 11, Iss. 8, pp. e1005095-e1005095
Open Access | Times Cited: 108
Targeting Ubiquitination for Cancer Therapies
John Kenneth Morrow, Hui‐Kuan Lin, Shao‐Cong Sun, et al.
Future Medicinal Chemistry (2015) Vol. 7, Iss. 17, pp. 2333-2350
Open Access | Times Cited: 103
Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity
Juan Tang, Guoxin Lin, Wallace Y. Langdon, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 92
GABA induced by sleep deprivation promotes the proliferation and migration of colon tumors through miR-223-3p endogenous pathway and exosome pathway
Haijun Bao, Zuojie Peng, Xukai Cheng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 24
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 816-837
Closed Access | Times Cited: 9
Targeting CBLB as a potential therapeutic approach for disseminated candidiasis
Yun Xiao, Juan Tang, Hui Guo, et al.
Nature Medicine (2016) Vol. 22, Iss. 8, pp. 906-914
Open Access | Times Cited: 84
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 6
E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor–mediated antifungal innate immunity
Lele Zhu, Tian-Ming Luo, Xia Xu, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 8, pp. 1555-1570
Open Access | Times Cited: 53
The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition
Serah Kimani, Sumera Perveen, Magdalena Szewezyk, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 15
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors
Adelphe M. Mfuh, Jeffrey A. Boerth, Gayathri Bommakanti, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1500-1512
Closed Access | Times Cited: 5
Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation
Yun Xiao, Guilin Qiao, Juan Tang, et al.
The Journal of Immunology (2015) Vol. 195, Iss. 9, pp. 4218-4227
Open Access | Times Cited: 43
Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials
Seyed Fazel Nabavi, Atanas G. Atanasov, Haroon Khan, et al.
Cancer Letters (2018) Vol. 434, pp. 101-113
Closed Access | Times Cited: 43
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells
Marie Lork, Jens Staal, Rudi Beyaert
Cellular Immunology (2018) Vol. 340, pp. 103877-103877
Open Access | Times Cited: 38
Germline mutation in Cbl proto-oncogene B is associated with inherited thrombocytopenia and predisposes megakaryocytes to ferroptosis
Xiang Xiao, Rongli Xie, Yang Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167765-167765
Closed Access
Rational Design, Optimization, and Biological Evaluation of Novel pyrrolo-pyridone Derivatives as Potent and Orally Active Cbl-b Inhibitors
Yixuan Zhang, Xiangna Guan, Yushuang Chai, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117488-117488
Closed Access
A computational study to identify potential inhibitors targeting the TKB domain of CBL-B
Sherif Elsabbagh
Discover Chemistry. (2025) Vol. 2, Iss. 1
Open Access
Circular RNA circSTX12 regulates osteo-adipogenic balance and proliferation of BMSCs in senile osteoporosis
Huimin Gu, Wenhui Yu, Pei Feng, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity
Poojitha Sitaram, Bradley Uyemura, Subramaniam Malarkannan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5821-5821
Open Access | Times Cited: 30
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies
Ryan C. Augustin, Wesley L. Cai, Jason J. Luke, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1724-1732
Closed Access | Times Cited: 3
Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy
Xiuqi Hu, Erdong Li, Yangguo Zhou, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 102, pp. 117677-117677
Closed Access | Times Cited: 3
Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression
Xiang Hu, Chaofeng Han, Jing Jin, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 31
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 14-31
Open Access | Times Cited: 24
Modulating Host Signaling Pathways to Promote Resistance to Infection by Candida albicans
Nick Carpino, Shamoon Naseem, David Frank, et al.
Frontiers in Cellular and Infection Microbiology (2017) Vol. 7
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top